Case report: Variant-specific pre-exposure prophylaxis of SARS-CoV-2 infection in multiple sclerosis patients lacking vaccination responses

Case report: Variant-specific pre-exposure prophylaxis of SARS-CoV-2 infection in multiple sclerosis patients lacking vaccination responses

Sphingosine-1-phosphate receptor modulators and anti-CD20 treatment are widely used disease-modifying treatments for multiple sclerosis. Unfortunately, they may impair the patient’s ability to mount sufficient humoral and T-cellular responses to vaccination, which is of special relevance in the cont...

Full description

Bibliographic Details
Main Authors: Christina Woopen, Urszula Konofalska, Katja Akgün, Tjalf Ziemssen
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Immunology
Subjects:
multiple sclerosis
sphingosine-1-receptor modulators (S1PR)
neutralizing antibody
prophylaxis
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
coronavirus disease (COVID-19)
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.897748/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.897748/full

Similar Items